BEZ235 (NVP-BEZ235, Dactolisib)

Catalog No.S1009

BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.

Price Stock Quantity  
USD 110 In stock
USD 170 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

BEZ235 (NVP-BEZ235, Dactolisib) Chemical Structure

BEZ235 (NVP-BEZ235, Dactolisib) Chemical Structure
Molecular Weight: 469.55

Validation & Quality Control

Cited by 81 publications:

8 customer reviews :

Quality Control & MSDS

Related Compound Libraries

BEZ235 (NVP-BEZ235, Dactolisib) is available in the following compound libraries:

PI3K Inhibitors with Unique Features

Product Information

  • Compare PI3K
    Compare PI3K Products
  • Research Area
  • Inhibition Profile
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.
Targets p110α [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)
mTOR (p70S6K) [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)

 View  More

IC50 4 nM 5 nM 6 nM 7 nM
In vitro BEZ235 significantly reduces the phosphorylation levels of the mTOR activated kinase p70S6K. BEZ235 results in a reduction of S235/S236P-RPS6 levels with IC50 of 6.5 nM. The activity of BEZ235 against mTOR is determined using a biochemical mTOR K-LISA assay with IC50 of 20.7 nM. BEZ235 shows slightly lower activity against its β paralogue with IC50 of 75 nM. The PI3K/Akt/mTOR pathway is often constitutively activated in human tumor cells. BEZ235 blocks PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. Both PTEN-null cell lines PC3M and U87MG show a dose-dependent reduction in cell proliferation when treated with increasing concentrations of BEZ235 with an average GI50 of 10-12 nM. [1] BEZ235 is an mTORC1/2 catalytic inhibitor. [2]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
Trypanosoma brucei bruceiM1HDO2FvfGmvaXPyc4Jq[WxiQYPzZZk>NFLiNZgyQCCqMUHEUXNQNWDjN5ROSW62aYTyfZBidm:|b33hcEBi[3Srdnn0fUB4cXSqIFXDOVAhd2ZiMD6wNFI2KM7:TR?=MWWyOFgxPTl2Nh?=
MCF7NV33VGFZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmjENE4xOS1zMECg{txONG\MZnY1QCCqNIfNR4pFVVORNYeweZdHUUN3ME2wMlc{KM7:TR?=NXfIUWJuOjN6N{G5NFQ>
HCT116NGLv[ZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mk\rNE4xOS1zMECg{txONWLFTJF{PDhiaB?=M1PRdmROW09?M2HtUGlEPTB;MT6xOkDPxE1?MlvKNlM5PzF7MES=
U87MGNXzYOmJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEDUWW8xNjBzLUGwNEDPxE1?M1yzcFQ5KGh?MnPHSG1UVw>?NFrxdnNKSzVyPUGuN|Ih|ryPMYSyN|g4OTlyNB?=
HBC4MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXiwMlAyNTFyMDFOwG0>MYC0PEBpNWjmdpdWVG:pIFfJOVA:NThwNkGgUS=>MXqyNlM{PjJ2Nh?=
BSY1MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF\mN2gxNjBzLUGwNEDPxE1?M{\LXlQ5KGh?NX7pfIx{VG:pIFfJOVA:NThwNEigUS=>Mn\xNlI{OzZ{NE[=
HBC5MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGLU[ocxNjBzLUGwNEDPxE1?NGi2TGo1QCCqMmXvUI9oKEeLNUC9MVcvQDdiTR?=NFrJUZozOjN|NkK0Oi=>
MCF7Mor0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXUbI5MOC5yMT2xNFAh|ryPMWC0PEBpMmfkUI9oKEeLNUC9MVgvOTZiTR?=MUCyNlM{PjJ2Nh?=
MDA-MB-231M{nZdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\TO3gxNjBzLUGwNEDPxE1?M2TBPVQ5KGh?MUfMc4chT0l3ME2tPE4xQSCPM3rofFIzOzN4MkS2
U251MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLHNE4xOS1zMECg{txONXniOFFZPDhiaB?=MV7Mc4chT0l3ME2tO{43PiCPMkHCNlI{OzZ{NE[=
SF268MnzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUKwMlAyNTFyMDFOwG0>NEHJfJc1QCCqNVvMNZIyVG:pIFfJOVA:NTdwOUKgUS=>MoTvNlI{OzZ{NE[=
SF295NVzFXGVRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPsSpFxOC5yMT2xNFAh|ryPNULpTIJxPDhiaB?=MluwUI9oKEeLNUC9MVgvOzFiTR?=M2DLSFIzOzN4MkS2
SF539NUGzVGp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HINFAvODFvMUCwJO69VQ>?NUKxdJNkPDhiaB?=NWLZcVROVG:pIFfJOVA:NThwNUmgUS=>M{LIU|IzOzN4MkS2
SNB75MnPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEXhdFUxNjBzLUGwNEDPxE1?NEjSSGg1QCCqNVLlb4JRVG:pIFfJOVA:NThwNUigUS=>NUDGbmdZOjJ|M{[yOFY>
SNB78MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUG2RYY1OC5yMT2xNFAh|ryPMlr4OFghcA>?M3nQXGxw\yCJSUWwQU05NjZ3IF2=M2fVOlIzOzN4MkS2
HCC2998M2PO[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXmwMlAyNTFyMDFOwG0>MXy0PEBpNXzxdllYVG:pIFfJOVA:NThwMEWgUS=>NW\SR4xUOjJ|M{[yOFY>
KM12NVvvWGxCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXrRUYU5OC5yMT2xNFAh|ryPMUK0PEBpNUnoU25SVG:pIFfJOVA:NTdwNUSgUS=>MWmyNlM{PjJ2Nh?=
HT-29MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TRRlAvODFvMUCwJO69VQ>?MUm0PEBpMXTMc4chT0l3ME2tO{44PSCPMnXQNlI{OzZ{NE[=
HCT15NYHmc296T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjGOnYxNjBzLUGwNEDPxE1?M13tfVQ5KGh?NFOyfpdNd2diR1m1NF0uQC5yMzDNM3vFS|IzOzN4MkS2
HCT116NELTUFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV[wMlAyNTFyMDFOwG0>NGq1R5Q1QCCqNHu5Um1Nd2diR1m1NF0uPy54MTDNNVjFXm0xOjJ|M{[yOFY>
NCI-H23NX3yd|duT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XyOVAvODFvMUCwJO69VQ>?M{faTVQ5KGh?NYXmZYcxVG:pIFfJOVA:NTdwNkSgUS=>MXyyNlM{PjJ2Nh?=
NCI-H226MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXznUGI3OC5yMT2xNFAh|ryPM3fXfFQ5KGh?MWLMc4chT0l3ME2tPE41PCCPNHfT[I0zOjN|NkK0Oi=>
NCI-H522NXnzb5lvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPN[Io1OC5yMT2xNFAh|ryPMoHUOFghcA>?NX\0VJRjVG:pIFfJOVA:NThwNEWgUS=>M4qzN|IzOzN4MkS2
NCI-H438NH\BVYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXW0OZBmOC5yMT2xNFAh|ryPMn\VOFghcA>?MlS0UI9oKEeLNUC9MVgvOTFiTR?=MkXKNlI{OzZ{NE[=
A549MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TJSFAvODFvMUCwJO69VQ>?NICyPVc1QCCqMnvxUI9oKEeLNUC9MVgvODdiTR?=MVGyNlM{PjJ2Nh?=
DMS273NIjGS|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXTNnMxNjBzLUGwNEDPxE1?MYS0PEBpNXP6RVJFVG:pIFfJOVA:NTdwOECgUS=>MXKyNlM{PjJ2Nh?=
DMS114M2\4PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVHMZY1pOC5yMT2xNFAh|ryPM3zGT|Q5KGh?M4f5c2xw\yCJSUWwQU05NjN7IF2=MV:yNlM{PjJ2Nh?=
LOXIMVINGnMZXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWD0UI9DOC5yMT2xNFAh|ryPM133PFQ5KGh?MmLDUI9oKEeLNUC9MVgvPjZiTR?=M3fKSlIzOzN4MkS2
OVCAR3MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\pNE4xOS1zMECg{txOM{i1WlQ5KGh?NHvzUGtNd2diR1m1NF0uQC5zNzDNMkH6NlI{OzZ{NE[=
OVCAR4MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEG4W4YxNjBzLUGwNEDPxE1?NE\ERWY1QCCqNEPPZoxNd2diR1m1NF0uQC53ODDNNGK2O5czOjN|NkK0Oi=>
OVCAR5NHfGeXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrHeWt1OC5yMT2xNFAh|ryPMk\IOFghcA>?M3m2VWxw\yCJSUWwQU04NjV5IF2=NFGwbHQzOjN|NkK0Oi=>
OVCAR8M3znV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVOwMlAyNTFyMDFOwG0>M1;EWFQ5KGh?Mn;1UI9oKEeLNUC9MVcvQDRiTR?=MYOyNlM{PjJ2Nh?=
SKOV3NHTtdnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HQUlAvODFvMUCwJO69VQ>?MkHzOFghcA>?NUjQXHJFVG:pIFfJOVA:NThwNEGgUS=>M4nGS|IzOzN4MkS2
RXF631LMoG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XMR|AvODFvMUCwJO69VQ>?NX7VWGJnPDhiaB?=M{OyZWxw\yCJSUWwQU05NjJzIF2=NETTOYQzOjN|NkK0Oi=>
ACHNMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;JS20xNjBzLUGwNEDPxE1?NF;4bGE1QCCqMmDUUI9oKEeLNUC9MVcvQTViTR?=NVfHUVA6OjJ|M{[yOFY>
St-4MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFe0V4MxNjBzLUGwNEDPxE1?NG\zdmo1QCCqNVP3cHp3VG:pIFfJOVA:NTdwNEegUS=>NF\JRZozOjN|NkK0Oi=>
MKN1MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYGwMlAyNTFyMDFOwG0>MXi0PEBpNHvsdoxNd2diR1m1NF0uQC52MTDNM2TiW|IzOzN4MkS2
MKN7M2jlUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYm1Zm9jOC5yMT2xNFAh|ryPMXu0PEBpNGTrSXlNd2diR1m1NF0uPy54ODDNNXm3fWJVOjJ|M{[yOFY>
MKN28NXzPbGtUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXGNE4xOS1zMECg{txOMUG0PEBpNULK[49EVG:pIFfJOVA:NTdwMEegUS=>M1vWN|IzOzN4MkS2
MKN45MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;kSJN[OC5yMT2xNFAh|ryPM4OxeVQ5KGh?MX;Mc4chT0l3ME2tPE4{PCCPNFjYTXUzOjN|NkK0Oi=>
MKN74Mn:zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rJTFAvODFvMUCwJO69VQ>?NEfYNHU1QCCqNF\5U3BNd2diR1m1NF0uPy52MjDNNV[xRZdLOjJ|M{[yOFY>
DU145MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NW\vcYdsOC5yMT2xNFAh|ryPMlX1OFghcA>?NFSwN2pNd2diR1m1NF0uQC5zNjDNM{HTcVIzOzN4MkS2
PC3Ml3pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVK0XnJnOC5yMT2xNFAh|ryPM3mwN|Q5KGh?MmT1UI9oKEeLNUC9MVgvPjZiTR?=M4LSfVIzOzN4MkS2
Trypanosoma brucei bruceiMXTGeY5kfGmxbjDBd5NigQ>?NXXBXFlnOjByIH7NM4r3NFEzKGh?NY\KT|RrTE2VTx?=NE[yUlRF\WO{ZXHz[UBqdiCyaH;zdIhwfGmmeXygbY5we2m2b3ygdIhwe3CqYYTlJIxmfmWuNGXsRmwzPDhyNUm0Oi=>
Trypanosoma brucei bruceiNF;oVlNHfW6ldHnvckBCe3OjeR?=M2Dv[|E5KGh?NGHjVnVFVVORM{L1bGlvcGmkaYTpc44hd2ZicnXj[ZB1d3JvbXXkbYF1\WRiZX7kc4N6fG:|aYOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5idILhcpNn\XK{aX6geZB1[WunM4W0OlI1QDB3OUS2
Trypanosoma brucei bruceiMUnGeY5kfGmxbjDBd5NigQ>?Mmf5NlAxKG6PMXSxNkBpMm\FSG1UVw>?MWXF[oZm[3Rib36gd5BpcW6pb335cIVqdiCuZY\lcC=>M33XeFI1QDB3OUS2
Trypanosoma brucei bruceiNHHlT3FHfW6ldHnvckBCe3OjeR?=NF7GNo0zODBibl2=MXWxNkBpNILre4FFVVORMoHaSYZn\WO2IH;uJJBpd3OyaHH0bYR6dGOqb3zpcoUhdGW4ZXy=NF\pV|EzPDhyNUm0Oi=>
UM-UC-3MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn7tTWM2OD1|MUWgdG0>M4PRSXNCVkeHUh?=
SBC-1NETHTlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4nPUmlEPTB;N{SyJJBOMl\UV2FPT0WU
MKN1NWe0R5ZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn7MTWM2OD1{Lkigcm0>NVT0cIt4W0GQR1XS
NCI-H720M3;4UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV[5XIw2UUN3ME2zMlU4KG6PM1TrV3NCVkeHUh?=
BFTC-909MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mo\3TWM2OD1|LkexJI5OMWHTRW5ITVJ?
BPH-1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoDNTWM2OD12Lke2JI5ONFPiSndUSU6JRWK=
PC-3M{G2dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTVwMEmgcm0>MoTBV2FPT0WU
AN3-CANF7jc5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XpSmlEPTB;NT61OkBvVQ>?M{\zbnNCVkeHUh?=
HNNFTQWGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HRS2lEPTB;NT65OkBvVQ>?NV\GbI5vW0GQR1XS
HCC2218Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUTxUoV1UUN3ME22MlYyKG6PMn:1V2FPT0WU
KP-4NH7keWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFf3UI1KSzVyPUegcm0>M2mwdHNCVkeHUh?=
LU-139Mnu4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\XbXdiUUN3ME23Mlc4KG6PM2nOSXNCVkeHUh?=
ETK-1Mm[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LPfWlEPTB;Nz64PEBvVQ>?MYPTRW5ITVJ?
Ramos-2G6-4C10MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHj2[HhKSzVyPUiuOFkhdk1?MkP4V2FPT0WU
MHH-PREB-1NIWzOmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfsZlZKSzVyPUmuNVIhdk1?MXXTRW5ITVJ?
DU-4475MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPNTWM2OD17LkS0JI5OMkW4V2FPT0WU
NCI-H1666M1LmOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTlwN{Ggcm0>NH:2dFBUSU6JRWK=
CAMA-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NILvPIRKSzVyPUmuPEBvVQ>?MWHTRW5ITVJ?
TYK-nuMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWi1TpE3UUN3ME25Mlk1KG6PMVfTRW5ITVJ?
MFE-280NIXnV4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWrtXGJQUUN3ME25Mlk6KG6PNGfoWY1USU6JRWK=
A549MmT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoD1TWM2OD1zMD6xOEBvVQ>?NEXGO3NUSU6JRWK=
769-PM2PtPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHXESXNKSzVyPUGwMlQ1KG6PMkK4V2FPT0WU
L-363NIDvcndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlntTWM2OD1zMD62PUBvVQ>?MYLTRW5ITVJ?
ES8Mlm1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2fvO2lEPTB;MUCuPUBvVQ>?NFHIflJUSU6JRWK=
PA-1MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTFzLkiyJI5OM{HUZnNCVkeHUh?=
MewoMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPDTWM2OD1zMT65PUBvVQ>?MmTVV2FPT0WU
HSC-3M{XWN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX76eW13UUN3ME2xNk4zOSCwTR?=MmG5V2FPT0WU
H4MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrCcVhKSzVyPUGyMlY4KG6PMk[1V2FPT0WU
BB65-RCCNXHEc4NTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PaemlEPTB;MUKuO|Ihdk1?M4DBR3NCVkeHUh?=
NCI-H1793NGq3[mlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHz5ZXpKSzVyPUGyMlgzKG6PNXnrVWh3W0GQR1XS
KARPAS-45MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHPGbpJKSzVyPUGzMlUyKG6PMYjTRW5ITVJ?
GCTMlXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkTnTWM2OD1zMz62PEBvVQ>?MkXvV2FPT0WU
EoL-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGLEc25KSzVyPUGzMlk{KG6PNYPieJF[W0GQR1XS
LB2241-RCCNVq0bZNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTF2LkCxJI5OMUfTRW5ITVJ?
ES5MkXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYPJR|UxRTF2Lke0JI5OM{jnV3NCVkeHUh?=
LOXIMVINFjz[IxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zvW2lEPTB;MUSuPVkhdk1?NXX1ZZJ3W0GQR1XS
COR-L105NH;FfXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jCNWlEPTB;MUWuNFQhdk1?MW\TRW5ITVJ?
P12-ICHIKAWAMkDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXLJR|UxRTF3LkGgcm0>NF71NHJUSU6JRWK=
CHL-1Ml7JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXfNXXpWUUN3ME2xOU41PSCwTR?=MU\TRW5ITVJ?
VMRC-RCZMUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFnoU|dKSzVyPUG1MlY{KG6PNXrrb5RyW0GQR1XS
HHMljFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXmTWM2OD1zNT63JI5OM1PoNnNCVkeHUh?=
NUGC-3NHLiOWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3j2XWlEPTB;MU[uN|Qhdk1?MXPTRW5ITVJ?
EGI-1MoCxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW[1eIw4UUN3ME2xOk41OyCwTR?=MljqV2FPT0WU
OS-RC-2M3LmZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVvIV5VDUUN3ME2xOk41PyCwTR?=MkDHV2FPT0WU
MOLT-16NUHrd2VDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXjdXBKSzVyPUG3MlE2KG6PMmflV2FPT0WU
NCI-H209NXG0Ooo3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLCTWM2OD1zNz6yPUBvVQ>?M1v3eXNCVkeHUh?=
697NHTkfW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml;STWM2OD1zNz60N{BvVQ>?MkPjV2FPT0WU
D-56MGMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXX0RldZUUN3ME2xO{43QSCwTR?=MX3TRW5ITVJ?
VA-ES-BJMoHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1Wxb2lEPTB;MUeuPFMhdk1?MYXTRW5ITVJ?
EW-16NYP1cWFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml:5TWM2OD1zOD6wOEBvVQ>?M33C[HNCVkeHUh?=
HGC-27NHfCTHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXzJR|UxRTF6LkC2JI5ONEKzcI5USU6JRWK=
ES7M2rIdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HCXGlEPTB;MUiuNFkhdk1?M121PXNCVkeHUh?=
HuH-7NWi4N3hVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3y2XmlEPTB;MUiuOEBvVQ>?MlTQV2FPT0WU
BCPAPM{K2SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWnJR|UxRTF6Lk[1JI5OMXTTRW5ITVJ?
SW1710M{Htfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHjOOlFKSzVyPUG4MlczKG6PNYPTNJB{W0GQR1XS
IST-MEL1MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEPtUlZKSzVyPUG4Mlc4KG6PMl\mV2FPT0WU
SF295NF;ZNIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmW3TWM2OD1zOD65N{BvVQ>?NITRTZVUSU6JRWK=
RPMI-7951MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1nmc2lEPTB;MUmuNlghdk1?MknCV2FPT0WU
SF126NXzBN2pkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVrsNGF5UUN3ME2xPU41OSCwTR?=MUPTRW5ITVJ?
GAMGM{[yZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUWxZ|YyUUN3ME2xPU41QCCwTR?=NY\2eYM{W0GQR1XS
KNS-81-FDMmHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mni4TWM2OD1zOT61OEBvVQ>?NUPhNlFtW0GQR1XS
RT-112MmnlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTF7Lk[2JI5OMUnTRW5ITVJ?
DELMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnqxTWM2OD1{MD60PUBvVQ>?NHTFPWdUSU6JRWK=
CGTH-W-1NFjZR3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4raOGlEPTB;MkCuOlMhdk1?NXLiV5RiW0GQR1XS
HOSM4DNfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnGc4dKSzVyPUKxMlA3KG6PM4DNOXNCVkeHUh?=
ES4M2DIN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTJzLkC4JI5ONV64bmdUW0GQR1XS
RXF393MonqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTJzLkS1JI5ONVrFWVBDW0GQR1XS
NCI-H2030MkewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml:3TWM2OD1{MT61NkBvVQ>?Mm\TV2FPT0WU
YH-13NH[4N2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jJdmlEPTB;MkGuPFghdk1?NIfPXGdUSU6JRWK=
HT-1080M{P1XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXMRYlKSzVyPUKxMlk{KG6PMkPjV2FPT0WU
NCI-SNU-1M1PIdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;0TWM2OD1{MT65OUBvVQ>?NYK2O5ZmW0GQR1XS
G-402NHP0d41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\YXpJKSzVyPUKyMlE3KG6PNWHiNpkxW0GQR1XS
786-0M4LDbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mkj2TWM2OD1{Mj6yPUBvVQ>?MVrTRW5ITVJ?
ME-180MnjvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWm2XpBSUUN3ME2yNk41OyCwTR?=M37jUXNCVkeHUh?=
NB69NFTkSWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTJ{LkWzJI5ONHHhW2tUSU6JRWK=
J-RT3-T3-5M{fBWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWn2[Hh2UUN3ME2yNk46PiCwTR?=M{G0N3NCVkeHUh?=
TGBC1TKBM3vhbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXuWJpKSzVyPUKzMlA2KG6PMnPWV2FPT0WU
SW780Mnf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3JR|UxRTJ|LkGzJI5OMljLV2FPT0WU
MG-63MojJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTJ|LkS1JI5ONWPaWoNDW0GQR1XS
BV-173NW[4ZWtZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTJ|Lki3JI5OM1K1VnNCVkeHUh?=
CAL-51NX7VRYgyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWj2THVsUUN3ME2yN{45QSCwTR?=MmjXV2FPT0WU
A375MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPsTWM2OD1{Mz65N{BvVQ>?NHnKb3dUSU6JRWK=
MEL-HOMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13rd2lEPTB;MkSuNFQhdk1?NWfncGw{W0GQR1XS
EFO-27M{f4b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nYcWlEPTB;MkSuN|Mhdk1?M{PVSXNCVkeHUh?=
Hs-578-TMnnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUOxR|JpUUN3ME2yOE42QCCwTR?=MYHTRW5ITVJ?
NBsusSRMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPJcG5KSzVyPUK0MlYhdk1?NXfKZYtDW0GQR1XS
CTB-1NFW1R|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPxTWM2OD1{ND62O{BvVQ>?NYDo[GE{W0GQR1XS
FTC-133MlTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTQUlgxUUN3ME2yOU4yKG6PMXjTRW5ITVJ?
MOLT-4MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHHnN4tKSzVyPUK1MlEzKG6PMUXTRW5ITVJ?
HO-1-N-1NGO3U2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTJ3LkG1JI5ONYPzeXVmW0GQR1XS
ES3M2\kUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPOSYtKSzVyPUK1MlIzKG6PMYDTRW5ITVJ?
TI-73M4XVZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\kVZdKSzVyPUK1MlI5KG6PNFfKcHlUSU6JRWK=
MPP-89M4P2SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLEUppnUUN3ME2yOU4{OiCwTR?=MlS4V2FPT0WU
KYSE-150NGXRfoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1zhXWlEPTB;MkWuPFkhdk1?MW\TRW5ITVJ?
LXF-289NXjxbnp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEjDXnhKSzVyPUK2MlA1KG6PM32wbXNCVkeHUh?=
SK-LU-1M2mzfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUTaclM4UUN3ME2yOk4yPyCwTR?=M1S3bXNCVkeHUh?=
HOP-92M{nYWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\pTWM2OD1{Nj60PEBvVQ>?NYSyemloW0GQR1XS
HuO9NFHMZYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTJ4Lke2JI5ONHf2UJNUSU6JRWK=
SW962M4DKS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX;hO2w3UUN3ME2yOk44PiCwTR?=NFHjPWZUSU6JRWK=
RS4-11MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYj0[ohsUUN3ME2yOk46OSCwTR?=NEDTbplUSU6JRWK=
NCI-H292Mo\wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnH3TWM2OD1{NzDuUS=>MVjTRW5ITVJ?
DBMmG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrVTWM2OD1{Nz6zOkBvVQ>?MnXtV2FPT0WU
SW1088NGfFUI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVqxOpZDUUN3ME2yPE4zQSCwTR?=MWXTRW5ITVJ?
A204NWKzfpBIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\ETY57UUN3ME2yPE41PyCwTR?=NF;VPFNUSU6JRWK=
A3-KAWM3HyZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYHJR|UxRTJ6Lk[0JI5OMV\TRW5ITVJ?
MV-4-11NYH6[XRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTscndKSzVyPUK4Mlchdk1?NVPqUpVEW0GQR1XS
ES1NFXpNlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nXVmlEPTB;MkiuPFQhdk1?M{fOOHNCVkeHUh?=
ONS-76M3;2e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mkj0TWM2OD1{OT6wOUBvVQ>?MnXvV2FPT0WU
D-263MGMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTJ7LkO1JI5OM1Xoe3NCVkeHUh?=
U-2-OSNWT5e49LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTJ7LkWgcm0>MUfTRW5ITVJ?
T98GNYL4T21RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3iWXFtUUN3ME2yPU45QCCwTR?=NInuVFNUSU6JRWK=
GI-ME-NNXfvZ3p7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnpdWdKSzVyPUK5MlkyKG6PMmHmV2FPT0WU
BHT-101NX7uNnBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXLTWM2OD1|MD6wOUBvVQ>?NVH1ZohSW0GQR1XS
NOS-1M1vwbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHHFW2NKSzVyPUOwMlEzKG6PNGDEfmhUSU6JRWK=
AsPC-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1fUfWlEPTB;M{CuNkBvVQ>?NFjmUFJUSU6JRWK=
QIMR-WILNHTqbolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4r2emlEPTB;M{CuOkBvVQ>?MoDNV2FPT0WU
JVM-3M4jOSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTNyLkizJI5OMmGyV2FPT0WU
KU-19-19NFXaW4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXPJR|UxRTNzLkGzJI5OM4nEO3NCVkeHUh?=
OVCAR-8NHiycGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTNzLkK2JI5ONXfsdpUyW0GQR1XS
BENM4fuVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVHGWog2UUN3ME2zNU43OyCwTR?=M{XSXXNCVkeHUh?=
BE-13M2nZeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzufGFxUUN3ME2zNU45OiCwTR?=MojoV2FPT0WU
EW-18Mm[1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLKTWM2OD1|MT64OkBvVQ>?NE\EVY9USU6JRWK=
ECC10NFzhd2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvUdXFKSzVyPUOxMlk2KG6PMY\TRW5ITVJ?
CTV-1NGf2e5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MonSTWM2OD1|Mj64NkBvVQ>?M4TT[nNCVkeHUh?=
COLO-800NW\IV4VtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLCTWZ5UUN3ME2zNk46OiCwTR?=Mmi2V2FPT0WU
A2058MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTRTWM2OD1|Mz6yOUBvVQ>?NX;Oc5VJW0GQR1XS
VM-CUB-1NEf3VHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLxSotIUUN3ME2zN{41OyCwTR?=M335XXNCVkeHUh?=
Ca9-22MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVPNRnFqUUN3ME2zN{42PSCwTR?=MlL0V2FPT0WU
COLO-684MlXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XRRWlEPTB;M{OuOVghdk1?MYfTRW5ITVJ?
RPMI-8226MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MULJR|UxRTN|LkiyJI5OMkfEV2FPT0WU
SK-NEP-1NHnwZ5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLqTWM2OD1|ND6xOUBvVQ>?NGDKVXZUSU6JRWK=
BeckerNIrrdppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHKc3VQUUN3ME2zOE4zOSCwTR?=NWnuc3llW0GQR1XS
NCI-H28MlixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXyyeodEUUN3ME2zOE41PCCwTR?=MVLTRW5ITVJ?
CAL-120M3rZO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTN2LkeyJI5OMnvnV2FPT0WU
MDA-MB-157MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGPhdm1KSzVyPUO1MlQyKG6PMnnPV2FPT0WU
OVCAR-5NVPGOpdTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4DZVWlEPTB;M{WuOFchdk1?NX7FOlBjW0GQR1XS
LAMA-84NIO2bYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTN3Lki3JI5OMoXIV2FPT0WU
CAKI-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvMdIgzUUN3ME2zOk41OyCwTR?=MX;TRW5ITVJ?
DaoyNWX2OGtOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRTN4Lkegcm0>MYPTRW5ITVJ?
CAL-62MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWi1c3I2UUN3ME2zOk45PiCwTR?=MVXTRW5ITVJ?
8-MG-BANUGy[ZI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGLxbo9KSzVyPUO3MlI2KG6PM3PTdHNCVkeHUh?=
8505CM3vSVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfXNlc5UUN3ME2zO{42OSCwTR?=Mlj5V2FPT0WU
LNCaP-Clone-FGCMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{nZSmlEPTB;M{euOVkhdk1?M{TrenNCVkeHUh?=
CAL-39MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTN5Lkmgcm0>Mm\vV2FPT0WU
MN-60MkfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4S2UWlEPTB;M{euPVYhdk1?NIjp[GxUSU6JRWK=
RKOMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTN6LkOzJI5ONX7a[o02W0GQR1XS
U251MlflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInjepBKSzVyPUO4MlQ{KG6PMnnyV2FPT0WU
SJSA-1NE\JOlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTN6LkW0JI5OMU\TRW5ITVJ?
CAL-12TNGDOfGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTN6Lk[gcm0>NUfmU|hyW0GQR1XS
HCC1419MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjYcVhKSzVyPUO4MlcyKG6PNInheGZUSU6JRWK=
CO-314MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\yW2lEPTB;M{iuO|Qhdk1?MmHrV2FPT0WU
LB1047-RCCMkTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInEOYVKSzVyPUO4MlgyKG6PMXvTRW5ITVJ?
A101DNYKx[nM1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPqTWM2OD1|OD65O{BvVQ>?M17BcXNCVkeHUh?=
MDA-MB-175-VIIM1H4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTN7LkWxJI5OMYjTRW5ITVJ?
MZ2-MELNXriU4dOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnEWJhKSzVyPUO5MlY3KG6PNFq4PYpUSU6JRWK=
NB5MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknoTWM2OD12MD62OEBvVQ>?M3nKW3NCVkeHUh?=
G-401NGfFPZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjxNZZKSzVyPUSwMlgzKG6PM1vH[HNCVkeHUh?=
HTM1OwOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvlTWM2OD12MT6wNkBvVQ>?M1W5enNCVkeHUh?=
8305CM1SyZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTRzLki3JI5ONVfIVVFpW0GQR1XS
BHYMl7sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTR{LkeyJI5OMlTmV2FPT0WU
NTERA-S-cl-D1MleyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LuWGlEPTB;NEOgcm0>MnrmV2FPT0WU
T-24MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\oXmlEPTB;NEOuPFMhdk1?NFXBSllUSU6JRWK=
EPLC-272HNV6yU4w5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4XnXmlEPTB;NESuN|khdk1?M{LKeXNCVkeHUh?=
PSN1NHP0R21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGmy[3NKSzVyPUS0MlQhdk1?M1;LVHNCVkeHUh?=
NCI-H2452M3G1VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1v4R2lEPTB;NESuOVghdk1?MXTTRW5ITVJ?
KS-1NXX1O3dTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVW3[|NmUUN3ME20OE43PiCwTR?=MW\TRW5ITVJ?
HD-MY-ZMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlmzTWM2OD12ND65NkBvVQ>?MmXkV2FPT0WU
KNS-62Mn:xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHz6dlZKSzVyPUS1MlM5KG6PM{DNXHNCVkeHUh?=
NOMO-1NYPwS2hPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnnMTWM2OD12NT64O{BvVQ>?NHLLUnFUSU6JRWK=
SK-HEP-1NHvCOXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\0c3ZKSzVyPUS2MlA1KG6PNVnuSYlHW0GQR1XS
IGR-1NUHGVnd7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\rRndqUUN3ME20Ok4yOyCwTR?=NFTnUpJUSU6JRWK=
KYSE-180NVfxfIdvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{P6cmlEPTB;NE[uNVchdk1?MYXTRW5ITVJ?
EW-22M{jXWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWm5VZRtUUN3ME20Ok4zKG6PM3\aTXNCVkeHUh?=
NCI-H1355MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTR4LkO0JI5OM3XDVXNCVkeHUh?=
DOHH-2M2e3T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\VXWlEPTB;NE[uN|chdk1?NFPZXJNUSU6JRWK=
A4-FukMoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTR4LkWyJI5OMlPDV2FPT0WU
PC-14MmHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPRTWM2OD12Nj61O{BvVQ>?MlP6V2FPT0WU
TE-5NVnjenZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1:1bGlEPTB;NE[uPFQhdk1?M4XYc3NCVkeHUh?=
LB996-RCCM3LlTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXr2ZXA1UUN3ME20O{4yQSCwTR?=NEnmc|NUSU6JRWK=
NCI-H1623NGXtRYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXTyO4xKUUN3ME20O{44PiCwTR?=NXLmVHNbW0GQR1XS
NCI-H1155NYTuVI9WT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXUZohNUUN3ME20PE4{OiCwTR?=NXPn[XpyW0GQR1XS
LoVoNVrMUmFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XFbGlEPTB;NEiuOEBvVQ>?Mm\HV2FPT0WU
MCF7NGLBN|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXLJR|UxRTR6LkW4JI5ONEHK[49USU6JRWK=
AGSMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnLETWM2OD12OD63O{BvVQ>?NVjjeG42W0GQR1XS
PFSK-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELxSYlKSzVyPUS5MlA3KG6PNFPVcHFUSU6JRWK=
22RV1M{LoWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXvT3VYUUN3ME20PU4xQSCwTR?=MVzTRW5ITVJ?
COR-L23NH3xT|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3SxUmlEPTB;NEmuNVYhdk1?MmrYV2FPT0WU
D-283MEDMljxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYnnN2d4UUN3ME20PU43OSCwTR?=M{frb3NCVkeHUh?=
SW982MnT3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7LeWdKUUN3ME20PU46OSCwTR?=MWTTRW5ITVJ?
SW620MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUnRdYhlUUN3ME21NE4{PiCwTR?=MlrMV2FPT0WU
KYSE-140NWW3SHlyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zFVWlEPTB;NUCuOVUhdk1?NFLxXHVUSU6JRWK=
GCIYMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NULzOox{UUN3ME21NE43PyCwTR?=NGn5Z29USU6JRWK=
MHH-ESS-1MoLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHuzTZlKSzVyPUWxMlk2KG6PMoP6V2FPT0WU
D-423MGMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTkUmhDUUN3ME21Nk4xQCCwTR?=NWD2WG9ZW0GQR1XS
SF539MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3j4UGlEPTB;NUKuN|Uhdk1?MWDTRW5ITVJ?
RPMI-2650MlftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTV{Lk[5JI5OM{\LenNCVkeHUh?=
GR-STNVjVPZFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEP4eWFKSzVyPUWyMlg4KG6PM4PK[XNCVkeHUh?=
YKG-1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2rjfWlEPTB;NUOgcm0>MmnnV2FPT0WU
SK-MES-1MlzYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrnTWM2OD13Mz6yOkBvVQ>?M3;4THNCVkeHUh?=
HLENHntSJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknOTWM2OD13Mz60O{BvVQ>?M1fUSnNCVkeHUh?=
RVH-421Mo[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnieZhKSzVyPUWzMlY4KG6PMX7TRW5ITVJ?
C32NHn0Z|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlK3TWM2OD13Mz64N{BvVQ>?MX7TRW5ITVJ?
GB-1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHWTWM2OD13ND6yJI5ONXrBUWZ7W0GQR1XS
SNB75MoLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTV2LkK2JI5OM1u2THNCVkeHUh?=
EM-2MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTV2LkSgcm0>MknJV2FPT0WU
RH-1NUnmVpJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn7JTWM2OD13ND63JI5ONUnuZWpCW0GQR1XS
NKM-1MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{nxdGlEPTB;NUSuPFEhdk1?NGDUNopUSU6JRWK=
NCI-H2405NGC0eXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTV2Lki4JI5OMkDvV2FPT0WU
KYSE-450NEjDUI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTV3LkG2JI5OMlXXV2FPT0WU
A704MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2Dvc2lEPTB;NUWuOVkhdk1?M3vLfHNCVkeHUh?=
HAL-01M3;iO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoTMTWM2OD13NT64N{BvVQ>?NF7Cd2hUSU6JRWK=
TE-11MlHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LtcWlEPTB;NUWuPVkhdk1?NHTuTXZUSU6JRWK=
DOKNFLteVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIT3blFKSzVyPUW2MlAzKG6PNVrIU49IW0GQR1XS
KY821NETCS5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzkTWM2OD13Nj6yJI5OMmPaV2FPT0WU
KGNNV[xTHkyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MULJR|UxRTV4LkOyJI5OMn7JV2FPT0WU
MC116Mmj6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDxXVBPUUN3ME21O{45KG6PMke5V2FPT0WU
PANC-08-13NELQbGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkj1TWM2OD13OD6wNUBvVQ>?NUHDemhXW0GQR1XS
KE-37NHO0VJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTV6Lke3JI5ONX\KWJNYW0GQR1XS
KYSE-410NVjGWFNJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTV7LkS3JI5OMVjTRW5ITVJ?
RO82-W-1MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4\2bWlEPTB;NUmuPUBvVQ>?NHTyN5NUSU6JRWK=
M14NInJTZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfGTWM2OD14MD6wOEBvVQ>?NXjNclBvW0GQR1XS
GI-1MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFG2b4ZKSzVyPU[wMlMhdk1?M4m4PXNCVkeHUh?=
ML-2NXi2Vmg2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEL1ZoFKSzVyPU[wMlYzKG6PM3zuWnNCVkeHUh?=
BFTC-905NEPWU2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFLQPYVKSzVyPU[wMlY2KG6PMnvTV2FPT0WU
DMS-273MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTZyLki3JI5OM4L0VnNCVkeHUh?=
MDA-MB-361MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXlTWM2OD14MTDuUS=>M4m5fnNCVkeHUh?=
MSTO-211HM{\lVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkLTTWM2OD14Mz61NUBvVQ>?NHrzRmVUSU6JRWK=
MEG-01MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\BWWlEPTB;NkOuOVIhdk1?Mo\FV2FPT0WU
M059JNHP4bI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH;pSXhKSzVyPU[zMlU5KG6PMoXzV2FPT0WU
LN-405NFTPemFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLDTWM2OD14Mz64OUBvVQ>?NWfK[GpFW0GQR1XS
NCI-H1581MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXruO3Q3UUN3ME22OE4xOyCwTR?=NWj4eWxnW0GQR1XS
TCCSUPNEOyR5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTZ2LkWzJI5ONGn0Om9USU6JRWK=
SW872NF\5NIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYC0RVlvUUN3ME22OE42PyCwTR?=NWfKRlc6W0GQR1XS
KYSE-510MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXZTWM2OD14NT63OUBvVQ>?M1LNdXNCVkeHUh?=
NCI-H1792NF;KdIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPUTWM2OD14Nj6xOUBvVQ>?MoLsV2FPT0WU
SW13NX\4RohYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTZ4LkWgcm0>MUfTRW5ITVJ?
TE-8NELGclZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIf4dVBKSzVyPU[2MlUzKG6PM4XHN3NCVkeHUh?=
SCHNX7S[oZQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnXCTWM2OD14Nz6xJI5OMnjRV2FPT0WU
NEC8MlPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PKTGlEPTB;NkeuNlQhdk1?M{LhOHNCVkeHUh?=
HuO-3N1MoPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTrTWM2OD14Nz6zNUBvVQ>?MlzvV2FPT0WU
EFM-19M2rnfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV24Ro1tUUN3ME22O{42KG6PM1vkR3NCVkeHUh?=
HEC-1NHrCT3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYmxT5UxUUN3ME22O{42OiCwTR?=MUfTRW5ITVJ?
T47DM1:4Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTZ5Lki3JI5OM1vifHNCVkeHUh?=
SNU-423MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTZ5Lkm4JI5OMWnTRW5ITVJ?
WM-115NHnUPG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XCWmlEPTB;NkiuNVQhdk1?MUDTRW5ITVJ?
CaR-1NH7vUo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH25U5JKSzVyPU[4MlI2KG6PM{ewZ3NCVkeHUh?=
KU812M1eyS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWizXlhjUUN3ME22PE43QSCwTR?=M2PSS3NCVkeHUh?=
AM-38NWPucG5UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MojjTWM2OD14OT6zNUBvVQ>?NV3ETWp4W0GQR1XS
KOSC-2MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zRUGlEPTB;NkmuPVchdk1?MnjuV2FPT0WU
MC-IXCMo\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHiTWM2OD15MD6wPEBvVQ>?MYPTRW5ITVJ?
SCC-4NG\PdI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2O3Z2lEPTB;N{GuN|ghdk1?M3qwXnNCVkeHUh?=
Calu-3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;ERm5KSzVyPUexMlk5KG6PMXnTRW5ITVJ?
RPMI-8866M4TO[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTd{LkiyJI5OMkjQV2FPT0WU
OVCAR-4M1n1dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTd|LkO2JI5OMkH1V2FPT0WU
OAW-42MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTd|LkO5JI5OMWTTRW5ITVJ?
ATN-1NFrze|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDMPGVKSzVyPUezMlg4KG6PNWP0TFNoW0GQR1XS
CHP-212NWTBfolWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4L0b2lEPTB;N{SuPVUhdk1?M1TkV3NCVkeHUh?=
C2BBe1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXRdYV{UUN3ME23OU4xOyCwTR?=M370O3NCVkeHUh?=
A498M2DWbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XWNmlEPTB;N{WuNVUhdk1?MXrTRW5ITVJ?
SH-4NImwTFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHCTWM2OD15NT6yNUBvVQ>?NYP2enRvW0GQR1XS
SNU-449MmWzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PITWlEPTB;N{WuO|khdk1?MljmV2FPT0WU
RDMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYPFb4ljUUN3ME23OU45PiCwTR?=NFHBT|FUSU6JRWK=
PANC-03-27M4HpSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LTZWlEPTB;N{[uNlUhdk1?MYnTRW5ITVJ?
S-117NVXa[Gk{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1e4SGlEPTB;N{[uNlchdk1?M1\jTHNCVkeHUh?=
SK-MEL-2NHr4fopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3LXdGlEPTB;N{[uO|Uhdk1?MWnTRW5ITVJ?
LK-2MmfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIDPWGtKSzVyPUe3MlA2KG6PMX\TRW5ITVJ?
CP50-MEL-BMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{LxcWlEPTB;N{euOEBvVQ>?MYXTRW5ITVJ?
647-VNV\iZoc4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVyyZ5FVUUN3ME23PE4xPyCwTR?=M4nMdHNCVkeHUh?=
LU-134-ANX3X[4dWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTd7LkCzJI5OMmj5V2FPT0WU
5637NXfRXIxWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXMTWM2OD15OT6yN{BvVQ>?MkTXV2FPT0WU
NCI-H1437MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHCTWM2OD16MD61JI5OM1z6V3NCVkeHUh?=
NCI-H460NGLjZVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:4SpZKSzVyPUixMlI{KG6PMUDTRW5ITVJ?
BxPC-3Mo\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRThzLkS2JI5OM2rRbnNCVkeHUh?=
CANM3;5T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HvZWlEPTB;OEGuPFQhdk1?MWLTRW5ITVJ?
KINGS-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DQcGlEPTB;OEKuN|Ihdk1?MoDwV2FPT0WU
OCUB-MMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;N[VBKSzVyPUiyMlQyKG6PNXXmd5NzW0GQR1XS
KALS-1NWrZ[FFMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\BO5RJUUN3ME24Nk42PCCwTR?=NWO5TWZJW0GQR1XS
OCI-AML2NGL3W2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mle4TWM2OD16Mj62NUBvVQ>?NGjobYtUSU6JRWK=
A253MmK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTh{Lk[1JI5ONFXnRXdUSU6JRWK=
LCLC-97TM1Mnr2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfiTWM2OD16Mj64OkBvVQ>?M2q1[3NCVkeHUh?=
NCI-H520NEPnSnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTh|LkC2JI5OM4PqVXNCVkeHUh?=
P30-OHKNGDzboFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XjR2lEPTB;OEOuOUBvVQ>?M17zPHNCVkeHUh?=
SBC-5M3PwZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTh|LkWyJI5OMYDTRW5ITVJ?
HCE-TNVWzZ5ZUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUH0S4RnUUN3ME24N{44PCCwTR?=M3XuS3NCVkeHUh?=
JEG-3MoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVv3dllNUUN3ME24OE4yKG6PM3TSUHNCVkeHUh?=
KG-1NED6T4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTh2LkK0JI5OM1HGVHNCVkeHUh?=
MIA-PaCa-2MlrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTh2LkW0JI5ONV;uRohkW0GQR1XS
CAL-33M334dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTh3LkC4JI5OMknJV2FPT0WU
639-VMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2[3S2lEPTB;OEWuOFIhdk1?M1LNbHNCVkeHUh?=
NCI-H1048MoTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XzSWlEPTB;OE[uN|Ehdk1?NIfIVZNUSU6JRWK=
NCI-H1573Mn7MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7CcJhKSzVyPUi3MlQ5KG6PMn7HV2FPT0WU
NCI-H2228NWLMZ4VQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTh6LkK2JI5OM2LGTXNCVkeHUh?=
NB14MlfLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmjMTWM2OD16OD6zJI5ONUXCe41nW0GQR1XS
SCC-25M{D2UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TacGlEPTB;OEmuPFIhdk1?MX7TRW5ITVJ?
A431Mn\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHpVnhKSzVyPUi5Mlk4KG6PNIS4XYxUSU6JRWK=
SN12CNVG4S2gxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3j2fWlEPTB;OUCuOlIhdk1?NF\veVBUSU6JRWK=
HuCCT1MkjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPFTWM2OD17MD63OkBvVQ>?MVzTRW5ITVJ?
LS-123MkLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLGXoVKSzVyPUmyMlE5KG6PNXzNb4Z6W0GQR1XS
CAL-85-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFficmlKSzVyPUmyMlQ5KG6PMWXTRW5ITVJ?
ES6MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2S0bmlEPTB;OUKuPFMhdk1?NFjhSYZUSU6JRWK=
NCI-H650MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1j4RWlEPTB;OUSuNFkhdk1?NGrLbWlUSU6JRWK=
NCI-H446NIrOSFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPUTWM2OD17NT6xNkBvVQ>?MVHTRW5ITVJ?
EW-13M3\3Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2\qbWlEPTB;OUWuO|Uhdk1?Moe1V2FPT0WU
HSC-2MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1T6VWlEPTB;OUWuPFkhdk1?M2e5UnNCVkeHUh?=
U031M4HGbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3e4V2lEPTB;OU[uO|Mhdk1?NFf2c5NUSU6JRWK=
EW-11NEjaTYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjETWM2OD17Nj64PEBvVQ>?NYjye2kyW0GQR1XS
GAKMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDNTWM2OD17OD65N{BvVQ>?NHu2Um1USU6JRWK=
SK-OV-3NYPk[4EyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3[3RWlEPTB;MUCwMlA4KG6PNUDSWXg1W0GQR1XS
OMC-1NFfLblJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWfQUGozUUN3ME2xNFAvOThibl2=NXz2NWZ4W0GQR1XS
TK10M4WwOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTFyMD6yNUBvVQ>?MXXTRW5ITVJ?
EKVXMkjuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTFyMD62JI5ONIrtWnNUSU6JRWK=
Detroit562MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLtUVhKSzVyPUGwNk4yPyCwTR?=NWn1[3dGW0GQR1XS
SF268NYjB[nF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPmN5FwUUN3ME2xNFIvOzRibl2=Ml;CV2FPT0WU
SNU-387M1z0RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TwR2lEPTB;MUC0MlE4KG6PNFXlbZJUSU6JRWK=
MDA-MB-231Mmm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTFyNT6wOkBvVQ>?NVyyfpJIW0GQR1XS
NCI-H1563NYXLbXNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jmfWlEPTB;MUC1MlE5KG6PMWrTRW5ITVJ?
D-502MGMlnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3n3TWlEPTB;MUC1Mlchdk1?NEG0VZBUSU6JRWK=
A2780NUfnWoJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\PV3FKSzVyPUGwOk41PyCwTR?=NH7vWpBUSU6JRWK=
IA-LMNHj2VY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjnTWM2OD1zMEeuOVEhdk1?MmTDV2FPT0WU
D-392MGMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF:wcpVKSzVyPUGwO{42PCCwTR?=MYjTRW5ITVJ?
MS-1MkfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWT6XnlQUUN3ME2xNFcvPzFibl2=MVjTRW5ITVJ?
SW1990Ml3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTFyOD61OEBvVQ>?NFjZSGlUSU6JRWK=
HELNGrWUHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTFyOT6yPUBvVQ>?MX;TRW5ITVJ?
SW1573NF\vVpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmfHTWM2OD1zMEmuN|Ehdk1?NYn1PFQ5W0GQR1XS
SW1783M2mwWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm[zTWM2OD1zMUCuNlIhdk1?M3XVfHNCVkeHUh?=
COLO-680NMnzYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnDXoZwUUN3ME2xNVAvPzZibl2=M{KyeXNCVkeHUh?=
NCI-N87MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTFzMT6wOEBvVQ>?M3PwNHNCVkeHUh?=
SK-MEL-28NYDsTG5xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX7sNYFPUUN3ME2xNVEvPTVibl2=NWHKTW44W0GQR1XS
BT-20NHf5NGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HXT2lEPTB;MUGyMlAyKG6PMl;CV2FPT0WU
NCI-H1648NGnWc49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIHtWlBKSzVyPUGxN{BvVQ>?NHLlU3RUSU6JRWK=
no-11NV:4b5NbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTFzMz6yPEBvVQ>?Mke3V2FPT0WU
MOLT-13MljBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHpS5dQUUN3ME2xNVMvPDRibl2=NHXJcIxUSU6JRWK=
NCI-H2170NFjwOFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTFzND61NUBvVQ>?MUHTRW5ITVJ?
HTC-C3NIPZUYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XOeWlEPTB;MUG2Mlg2KG6PNV3wZ2VqW0GQR1XS
LU-99AM4C2W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3X2O2lEPTB;MUG3MlIyKG6PM3\XVnNCVkeHUh?=
HCC2998NWHKeHJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoDOTWM2OD1zMUeuPVIhdk1?M4DsXHNCVkeHUh?=
NB13M4W0Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnJd2dIUUN3ME2xNVcvQTlibl2=NFXuSG5USU6JRWK=
GT3TKBMmLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXE[lZCUUN3ME2xNVgvODhibl2=NF\hc49USU6JRWK=
BT-549NX:zdHc6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvTTWM2OD1zMUiuPVUhdk1?NHvvZ|BUSU6JRWK=
NCI-H747Mm\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTFzOT6zOEBvVQ>?Mo\XV2FPT0WU
EW-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHHRpdyUUN3ME2xNlAvOiCwTR?=M4e4VHNCVkeHUh?=
LB831-BLCNG\UVmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\VS|JKSzVyPUGyNE43OyCwTR?=NVjHNmpqW0GQR1XS
NMC-G1NYPnfYhIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3qxOWlEPTB;MUKxMlEyKG6PMV7TRW5ITVJ?
COLO-679MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HzZ2lEPTB;MUKyMlE2KG6PMWPTRW5ITVJ?
HL-60NVXQdVAyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zPb2lEPTB;MUKzMlEhdk1?M2HwdnNCVkeHUh?=
MKN7M2LCS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{PIVmlEPTB;MUKzMlg{KG6PMoniV2FPT0WU
RERF-LC-MSMXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;hdmlEPTB;MUK0MlMyKG6PNHrnS2lUSU6JRWK=
DMS-114NEnEbnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVOzfpNRUUN3ME2xNlUvODlibl2=MV\TRW5ITVJ?
HuP-T4NXLob2syT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\XZ2lEPTB;MUK2Mlk4KG6PNG\GVoxUSU6JRWK=
HCC2157Mo\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX63PFhSUUN3ME2xNlcvPSCwTR?=MoCwV2FPT0WU
SKG-IIIaNY\wZ|JpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3Oyc2lEPTB;MUK4Mlghdk1?M4fEfHNCVkeHUh?=
HCT-116NEXLRppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGeyUoRKSzVyPUGzNE43PCCwTR?=MXjTRW5ITVJ?
BB30-HNCM3y4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vHcGlEPTB;MUOwMlc5KG6PMYPTRW5ITVJ?
KYSE-270NGfoZ4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTF|MD64PEBvVQ>?MVrTRW5ITVJ?
MFM-223NHPvO5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInRdXNKSzVyPUGzNU42OSCwTR?=MmTkV2FPT0WU
NH-12NWnMZZNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLa[mlxUUN3ME2xN|IvQTlibl2=NUnhT4QzW0GQR1XS
U-118-MGMnjiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjGPG1KSzVyPUGzN{43OiCwTR?=NH3rdZdUSU6JRWK=
ESS-1M3nO[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jDWWlEPTB;MUO1MlE5KG6PNELPW3lUSU6JRWK=
D-247MGM{O2cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTF|NT6yNUBvVQ>?NIDGbJJUSU6JRWK=
IGROV-1NHn3[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rpcmlEPTB;MUO1Mlc3KG6PMmrCV2FPT0WU
C-33-AM4XBOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXYZYhWUUN3ME2xN|UvQTdibl2=NGTlOIZUSU6JRWK=
NCI-H1693M2rUTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTF|Nj6xNkBvVQ>?MVLTRW5ITVJ?
MLMANXPwcVBjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTF|Nj61PEBvVQ>?NYnJcoNWW0GQR1XS
SK-N-ASMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPGbmJKSzVyPUGzO{4yPyCwTR?=MnPJV2FPT0WU
NCI-H1755NFiz[VNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzsVFBKSzVyPUGzPE45PSCwTR?=NITObFZUSU6JRWK=
CHP-134M2\jNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojrTWM2OD1zM{muOVUhdk1?MoLDV2FPT0WU
LS-513M32zPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV;5coxwUUN3ME2xOFAvQTFicF2=MXjTRW5ITVJ?
TE-12MoTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mle5TWM2OD1zNECuPVMhdk1?NUHObpFTW0GQR1XS
KNS-42MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnTvTWM2OD1zNESuN{BvVQ>?NX;RblJtW0GQR1XS
SJRH30M1fRVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX74Tm9zUUN3ME2xOFQvPDRibl2=NFfoO3ZUSU6JRWK=
NCI-H1092M2\WcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\od|VxUUN3ME2xOFQvPTJibl2=NH:5SJZUSU6JRWK=
H-EMC-SSM13BcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVjheI84UUN3ME2xOFYvQDFibl2=MkP5V2FPT0WU
SK-MEL-3NIiyVY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEe4XY1KSzVyPUG0O{42PSCwTR?=MVXTRW5ITVJ?
SK-N-FINYmxclRbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTCTWM2OD1zNEeuOVkhdk1?MoHnV2FPT0WU
NCI-H2126NGf4bodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULZUnFyUUN3ME2xOFgvOTVibl2=MkH2V2FPT0WU
NCI-H1299NUHEdpRXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTF3MD6yNkBvVQ>?M2C4WnNCVkeHUh?=
CFPAC-1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTF3MD62OkBvVQ>?MVnTRW5ITVJ?
NCI-H661NYPtPWRxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFToS4tKSzVyPUG1NU4zPiCwTR?=MUjTRW5ITVJ?
KYSE-70NIPSTJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTwTWM2OD1zNUGuO|khdk1?M4nWZXNCVkeHUh?=
SW900MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjiTnlnUUN3ME2xOVQvPjVibl2=M1z2T3NCVkeHUh?=
Ca-SkiNITNTnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXX5eFlOUUN3ME2xOVYvOzlibl2=NYPacIlwW0GQR1XS
HPAF-IINXe0eo03T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjqdY03UUN3ME2xOVYvPDdibl2=NX7qSZZoW0GQR1XS
LB2518-MELMlu1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3JR|UxRTF3Nz6xJI5OM2PkUHNCVkeHUh?=
LC-2-adMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\LTWM2OD1zNUiuOlIhdk1?MmjzV2FPT0WU
HCC1806MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3WWVRKSzVyPUG2O{45QCCwTR?=NEPJU4tUSU6JRWK=
UACC-62Mn;3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTF4OD6wPUBvVQ>?M{DGTnNCVkeHUh?=
KM-H2MmPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nueWlEPTB;MUewMlU5KG6PM1fyXnNCVkeHUh?=
NCI-H2347MojlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmW2TWM2OD1zN{KuO|Ihdk1?M1e5dnNCVkeHUh?=
SCC-15NWTreJJyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIjoc49KSzVyPUG3N{43PiCwTR?=NH;yZ2JUSU6JRWK=
BB49-HNCM{\3VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1PITmlEPTB;MUezMlgyKG6PMUTTRW5ITVJ?
GMS-10NF24d|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nzV2lEPTB;MUezMlk1KG6PMl;pV2FPT0WU
NCI-H2052MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2W3SWlEPTB;MUe0Mlkhdk1?NWizNFRsW0GQR1XS
SW626MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTF5Nj6wOkBvVQ>?NHztT2JUSU6JRWK=
MDA-MB-415NFzXdVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2jHUWlEPTB;MUe2MlYyKG6PNI\2TpBUSU6JRWK=
Saos-2M3LIb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PQfWlEPTB;MUe5MlM2KG6PMYXTRW5ITVJ?
DK-MGMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nEV2lEPTB;MUiwMlMhdk1?MVHTRW5ITVJ?
SNU-C2BNUfvNGp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\uTWM2OD1zOECuO|Mhdk1?NVGxU|N{W0GQR1XS
A427M{fCUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TCRWlEPTB;MUiyMlU4KG6PNXn6eohjW0GQR1XS
KP-N-YSM3W3OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3O3VWlEPTB;MUi1JI5OM4D3OnNCVkeHUh?=
J82NXTIOmttT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUPJR|UxRTF6NT6xPEBvVQ>?NIfMb4pUSU6JRWK=
LS-411NMkPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTF6Nz6yPEBvVQ>?MoWwV2FPT0WU
HCC1937MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTF6Nz60PUBvVQ>?M4rTenNCVkeHUh?=
OE33Mk\JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUO1UpU1UUN3ME2xPFgvQTdibl2=M3rrN3NCVkeHUh?=
NB7NXjQPWV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFHaeoZKSzVyPUG4PU45QSCwTR?=MUHTRW5ITVJ?
SW684NY\CNpR7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX3CR|JyUUN3ME2xPVYvOTNibl2=M1XyR3NCVkeHUh?=
HT-144M4DPcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnBTWM2OD1zOU[uNVUhdk1?MXPTRW5ITVJ?
SK-MEL-30NHfYNWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\rbmFKSzVyPUG5Ok4zKG6PM3nnXHNCVkeHUh?=
DBTRG-05MGMn30S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH7sVJhKSzVyPUG5PE41PyCwTR?=M4DpNnNCVkeHUh?=
NCI-H1395NVfpeVFKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTF7OD64OUBvVQ>?NHjKOI1USU6JRWK=
NCI-H2122M4rkSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXlTWM2OD1{MECuOVkhdk1?M2ThRnNCVkeHUh?=
no-10NGTLO3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTJyMT6wOEBvVQ>?MVfTRW5ITVJ?
SW48NVfON3JxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPWTWM2OD1{MEGuN|Ehdk1?NWHkW2V7W0GQR1XS
NCI-H1650NWW4NXd5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjKTWM2OD1{MESuNFEhdk1?Mo\aV2FPT0WU
MZ1-PCMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHH4UY9KSzVyPUKwOU42QCCwTR?=MXPTRW5ITVJ?
U-266NF[0WmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzQb|ZKSzVyPUKwOU44QSCwTR?=MlHaV2FPT0WU
CAS-1MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVWyV21PUUN3ME2yNFcvPDRibl2=NYTHbZJTW0GQR1XS
AU565NYH3[nRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M162fGlEPTB;MkGyMlgzKG6PM3\1TXNCVkeHUh?=
UACC-257NFz4Z|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX7JR|UxRTJzMz65PUBvVQ>?MXPTRW5ITVJ?
CAL-27M2fHXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\O[2lEPTB;MkG3MlA2KG6PNYj5NFk3W0GQR1XS
NCI-H23MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTJzOT6zN{BvVQ>?NELSPXZUSU6JRWK=
TE-6NWjxd|M6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTJzOT62PEBvVQ>?NX;1[HhpW0GQR1XS
TGBC24TKBNYrHSnY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrITWM2OD1{MkKuNVchdk1?MXLTRW5ITVJ?
TE-1M2DweWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPvTWM2OD1{MkKuPFghdk1?NWjDOHp2W0GQR1XS
RCC10RGBMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEDkc3ZKSzVyPUKyOE4yQSCwTR?=NHnjT29USU6JRWK=
NCI-H596MnnNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFSxRnlKSzVyPUKyPE4zOiCwTR?=MXzTRW5ITVJ?
SW954Mmf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTJ|Mz64N{BvVQ>?M2nwTHNCVkeHUh?=
NCI-H2087M3fwUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWPJR|UxRTJ|ND61NUBvVQ>?M4PtOnNCVkeHUh?=
SK-PN-DWNXj1[41IT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTJ|NT6xPUBvVQ>?NGj0[plUSU6JRWK=
KM12NVPpZZRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDsSXFlUUN3ME2yN|UvPyCwTR?=MWjTRW5ITVJ?
BT-474M3\acWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\EVGlEPTB;MkO1Mlc{KG6PM4TocnNCVkeHUh?=
IST-MES1M2\zOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTJ|Nj61O{BvVQ>?NUTu[2hFW0GQR1XS
HT-1197NFuzbIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWT6XmhzUUN3ME2yN|gvODlibl2=MkLDV2FPT0WU
CAL-54Mn\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLlTWM2OD1{M{iuOFkhdk1?MVjTRW5ITVJ?
NB10MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Moj1TWM2OD1{NECuNFYhdk1?NGj5VpNUSU6JRWK=
PANC-10-05MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{eyN2lEPTB;MkS1MlU3KG6PNFTENlJUSU6JRWK=
NCI-H522MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLaS41KSzVyPUK0PE4{OSCwTR?=NEjFR49USU6JRWK=
A388NY\XVlhDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlH0TWM2OD1{NEmuPFIhdk1?MnHLV2FPT0WU
GOTONXjtdY41T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnTbGJzUUN3ME2yOVAvOjlibl2=NGDXeJpUSU6JRWK=
KLEMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHDbVV6UUN3ME2yOVEvQDdibl2=NVG5fpRRW0GQR1XS
KYSE-520NUTtOJBnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1;vdGlEPTB;MkWyMlg3KG6PNWjC[5dIW0GQR1XS
HCE-4NI\sU2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLKS21HUUN3ME2yOlIvPSCwTR?=NWXEcYMxW0GQR1XS
KURAMOCHINX7BNXFJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEP1VYhKSzVyPUK2OU46KG6PMkP3V2FPT0WU
HCC38MmTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTJ4Nj60PEBvVQ>?MoroV2FPT0WU
FADUMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7GdnZKSzVyPUK2Ok43OyCwTR?=M{TVSnNCVkeHUh?=
CW-2NVfR[FlYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX73UVM3UUN3ME2yOlkvQTZibl2=NYLIWoJ7W0GQR1XS
L-428NXH0XlZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTJ5NT6xOUBvVQ>?M{HocXNCVkeHUh?=
HCC1569M4[y[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILr[ZpKSzVyPUK3OU45PCCwTR?=NY\LbZBEW0GQR1XS
NCI-H810NH\jWHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnhVGU4UUN3ME2yO|gvOzFibl2=M1H0e3NCVkeHUh?=
LB771-HNCMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFL3OVlKSzVyPUK4OU45PCCwTR?=NEft[ItUSU6JRWK=
LCLC-103HNF63UXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\kTWM2OD1{OEWuPVkhdk1?M{jrO3NCVkeHUh?=
EFO-21MnjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfjV4Y5UUN3ME2yPFcvPjhibl2=MlGwV2FPT0WU
CAL-72MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGDod|lKSzVyPUK5N{4yQSCwTR?=M2LvW3NCVkeHUh?=
SCC-9MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXJTWM2OD1{OUOuNlIhdk1?M2eydnNCVkeHUh?=
COLO-829NEHDc4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGTh[VRKSzVyPUK5Ok42KG6PMYrTRW5ITVJ?
U-87-MGNWHkWZZZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVu5bWlTUUN3ME2zNFAvPzNibl2=M1fCSXNCVkeHUh?=
MZ7-melMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTN{Mz63OkBvVQ>?MkPWV2FPT0WU
NCI-H1770NFHDW5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoHOTWM2OD1|Mk[uO|Qhdk1?NFrKUZNUSU6JRWK=
ChaGo-K-1M{\DVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TVTWlEPTB;M{K4MlEhdk1?NYXORndIW0GQR1XS
SiHaNWDtXGh4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXaTWM2OD1|MkmuNlQhdk1?NVXZdHQ2W0GQR1XS
NCI-SNU-5MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTTTZRbUUN3ME2zN|YvPzdibl2=NInKbZBUSU6JRWK=
DJM-1NVXFeXFtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTFdFNoUUN3ME2zOFAvOzNibl2=NUfIZnFUW0GQR1XS
OE19MmXtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPOVoZ1UUN3ME2zOFAvPTNibl2=M3zH[3NCVkeHUh?=
NCI-H1651M2jTR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTN2ND6xPEBvVQ>?MVLTRW5ITVJ?
COLO-792NFTmcmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTN3ND60NkBvVQ>?M4OyNHNCVkeHUh?=
ACHNNEPtNZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTN3Nj63NUBvVQ>?Mn;yV2FPT0WU
TH-3M3Xt[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHHUVXVKSzVyPUO3PU46PSCwTR?=Moj0V2FPT0WU
HT-1376NHvkT29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2PCOWlEPTB;M{i0Mlg5KG6PM3vaNXNCVkeHUh?=
RH-18NXW5OVZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjmTWM2OD1|OUSuO|Qhdk1?NUnLcpFVW0GQR1XS
NB6MlrhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NInPUlBKSzVyPUO5Ok43PiCwTR?=M125V3NCVkeHUh?=
COLO-320-HSRM3zBWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2X1W2lEPTB;NECzMlM4KG6PMWHTRW5ITVJ?
UACC-893MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnfwTWM2OD12ME[uOFchdk1?M2XPZnNCVkeHUh?=
DSH1MkfJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3fXe2lEPTB;NEC2MlkyKG6PNH:zZ4FUSU6JRWK=
TE-10NX;4SIZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTRyNz6wNUBvVQ>?NUC3PZZnW0GQR1XS
HCC70NYTwdWdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTRyOT6yNUBvVQ>?NIP6Z|NUSU6JRWK=
TGBC11TKBNF3jUYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWrJR|UxRTRzMD6zN{BvVQ>?M2DaO3NCVkeHUh?=
NCI-H727NHXROXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NETrXVhKSzVyPUSxNk4yOSCwTR?=MoPlV2FPT0WU
ALL-PONXnrboNxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3H5[GlEPTB;NEG1MlY6KG6PM4LhPHNCVkeHUh?=
ABC-1NUfVOlljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{XMNWlEPTB;NEKwMlQ2KG6PNV:xT4Q5W0GQR1XS
NCI-H69NFHaOGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULicJA2UUN3ME20NlYvPzZibl2=MY\TRW5ITVJ?
GP5dNFTMZ|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1f2bGlEPTB;NEO0MlQyKG6PMUHTRW5ITVJ?
UMC-11NF7IVJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVLJR|UxRTR3OD6zOkBvVQ>?MkHMV2FPT0WU
RMG-IMn60S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlzVTWM2OD12NkeuOVYhdk1?NGjDXYlUSU6JRWK=
YAPCNHzlRopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTR7MD62JI5OMYHTRW5ITVJ?
LS-1034MknqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTR7MT6wOkBvVQ>?NIHXOllUSU6JRWK=
RCM-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGWxd|hKSzVyPUS5Ok43QCCwTR?=NFT4UI1USU6JRWK=
HCC1954NF7WSmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV;0dpcxUUN3ME21NVIvPSCwTR?=MXnTRW5ITVJ?
SK-MEL-24NFHk[2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWniZ5A2UUN3ME21NVYvPTFibl2=MVjTRW5ITVJ?
NB12NYKw[GZMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfXTWM2OD13MkiuOFIhdk1?NXq1NoVNW0GQR1XS
SW756NF3sb5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGHrV41KSzVyPUW1OE46PiCwTR?=M4nTdnNCVkeHUh?=
HCC1187Mn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn3yTWM2OD13N{WuPFMhdk1?NXjMem5ZW0GQR1XS
NCI-H2342MnfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3r4SWlEPTB;NUmwMlM6KG6PM1LYOXNCVkeHUh?=
NCI-H2291M4PvVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjxdpl3UUN3ME21PVgvOzFibl2=NWrCd3BvW0GQR1XS
OVCAR-3NILTOXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{DTWGlEPTB;NUm4Mlk3KG6PMoDrV2FPT0WU
MHH-NB-11MlfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFPSVGFKSzVyPU[yPU4xOSCwTR?=NEPZNHVUSU6JRWK=
SASMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17tOWlEPTB;NkWyMlY4KG6PMlPDV2FPT0WU
COLO-824MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoDwTWM2OD14OEmuN|chdk1?M4fnTHNCVkeHUh?=
HCC1395NWH0OY4xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1TmdWlEPTB;Nkm4MlUhdk1?MUfTRW5ITVJ?
COLO-668MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGLFPJlKSzVyPUewOk4yKG6PMXPTRW5ITVJ?
NCI-H226M3;MNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDOTWM2OD15MEeuPEBvVQ>?M1\nUXNCVkeHUh?=
NB17M13jVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEK5SYJKSzVyPUeyNU44PSCwTR?=NGj4WIZUSU6JRWK=
SW1463NVr2S3ZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3m1TGlEPTB;N{O5MlE6KG6PNEf4dXFUSU6JRWK=
TGWNVLEeWlzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1nLVmlEPTB;N{[wMlE2KG6PNI\1elVUSU6JRWK=
NCI-H526M1TIXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXFSndKSzVyPUiyN{42OyCwTR?=NHPhN|JUSU6JRWK=
COR-L88MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PwSGlEPTB;OES4MlEzKG6PMVzTRW5ITVJ?
NCI-H441NGHSXFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTh7NT6yNkBvVQ>?NIrBeWpUSU6JRWK=
NCI-H630M2jGc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTlzMj65OkBvVQ>?MWLTRW5ITVJ?
Mo-TMm\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTl2Nz64PEBvVQ>?M1PuXnNCVkeHUh?=
JARMkPIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHRTWM2OD17NU[uNlQhdk1?MlO4V2FPT0WU
NCI-H1838MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\2fmlEPTB;MT6wNlM5QCEQvF2=NH3yTotUSU6JRWK=
DoTc2-4510MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{G4fWlEPTB;MT6wO|M4PiEQvF2=NFHrUmJUSU6JRWK=
MKN28NUXDb5l7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH3FUYdKSzVyPUGuNFkxOjRizszNMmLCV2FPT0WU
HuP-T3NYG0cZhRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTFwMUG5NFUh|ryPNXP2PG4yW0GQR1XS
TE-9Mn7VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XLRmlEPTB;MT6xNlk4OyEQvF2=Mkn5V2FPT0WU
NYNWLie|lsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUGxXVJTUUN3ME2xMlE3Pzl{IN88US=>M3HOZnNCVkeHUh?=
HT55M{TXbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfjTWM2OD1zLkOxN|Q1KM7:TR?=Mni2V2FPT0WU
SW837NV3hZ|RzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4W3OGlEPTB;MT6zNlk4QCEQvF2=M{L4Z3NCVkeHUh?=
NCI-H2029M1rmOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXPTWM2OD1zLkSxO|kyKM7:TR?=NI\XPJRUSU6JRWK=
IST-SL1NXLW[JRVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nMNWlEPTB;MT60OFI1KM7:TR?=M4mzO3NCVkeHUh?=
COLO-741NUi5cpFqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnJSJFwUUN3ME2xMlQ6PzdzIN88US=>NF\NPYhUSU6JRWK=
LU-65MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;6c|Y5UUN3ME2xMlYzOjR7IN88US=>MUnTRW5ITVJ?
NCI-H1304M4O3TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTFwNkW0PVgh|ryPMoPRV2FPT0WU
KARPAS-299NWC3TYpoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLaTWM2OD1zLke5OFc6KM7:TR?=M3flRnNCVkeHUh?=
NCI-H358MlrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NELKWHlKSzVyPUGuPVU2ODNizszNM3jVTnNCVkeHUh?=
OAW-28NULpdVZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH3ie4ZKSzVyPUKuNFY6OTlizszNMVzTRW5ITVJ?
C8166MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnizTWM2OD1{Lk[zN|kzKM7:TR?=NFz2VFhUSU6JRWK=
COLO-678NGPt[ZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjwTWM2OD1{LkizO|Y5KM7:TR?=MV;TRW5ITVJ?
SK-N-DZNV3nVJRvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PiZ2lEPTB;Mj64OlM5OSEQvF2=M{T3[nNCVkeHUh?=
NCI-H82MoHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPqTWM2OD1{LkmwN|Y6KM7:TR?=NIj5foNUSU6JRWK=
JVM-2NXvOcHpVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nCRmlEPTB;Mz6wN|E5QCEQvF2=MnHuV2FPT0WU
SW1116NVfZdpFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7pOYhKSzVyPUOuNFU1OTFizszNNFnnbY9USU6JRWK=
MDA-MB-453M3LWZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTNwMUC0N|kh|ryPNX7kNGhuW0GQR1XS
Calu-6M1jPVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV3oPIgzUUN3ME2zMlE6QTdizszNNXTxOGF6W0GQR1XS
SHP-77NVHxRldZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3\IUmlEPTB;Mz61Nlgh|ryPMXPTRW5ITVJ?
Capan-2NFuwbmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2CzRWlEPTB;ND6zNlU5OSEQvF2=NGDKOINUSU6JRWK=
SW948M2HJXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{fWXWlEPTB;ND63OFc4QSEQvF2=NELKSVZUSU6JRWK=
HDLM-2NGXhSo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlroTWM2OD13LkC3O|I2KM7:TR?=M3LRNXNCVkeHUh?=
LAN-6NGOxeFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DCO2lEPTB;Nj6yNVQ6PSEQvF2=MkDHV2FPT0WU
LU-135MoPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTZwNEOwO|ch|ryPMYrTRW5ITVJ?
T84M3nKSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3kNWVKSzVyPU[uPVg3PCEQvF2=M{SxXnNCVkeHUh?=
CAPAN-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXfRVVZZUUN3ME23MlYzOjN|IN88US=>M2P0N3NCVkeHUh?=
SW1417M{TkOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;4SGlEPTB;Nz65NVc{OSEQvF2=MnH5V2FPT0WU
BALL-1MlzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRThwNUC0NFkh|ryPMoXzV2FPT0WU
HT-29M3zsTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTlwMEe1PVkh|ryPMkX6V2FPT0WU
C3ANXvDcXJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHxTWM2OD17Lki4N|k1KM7:TR?=MoqxV2FPT0WU
NCI-H1993MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUTGXVFyUUN3ME2xNE42ODhzIN88US=>NHnOSVRUSU6JRWK=
SK-MEL-1NETtc3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXFdnBDUUN3ME2xNU43Ojh7IN88US=>NWex[5l6W0GQR1XS
DU-145MmXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTF2LkWwOVIh|ryPNHrVbnBUSU6JRWK=
KP-N-YNMmX1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTF2LkWxNFMh|ryPMnG2V2FPT0WU
CCRF-CEMNGfoRXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPaTWM2OD1zND63PFA6KM7:TR?=NHizSZlUSU6JRWK=
ZR-75-30M2jPOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MU\JR|UxRTF4LkOzNFMh|ryPMoDiV2FPT0WU
A673MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{XPW2lEPTB;MkCuOVUxPyEQvF2=NGK3dHFUSU6JRWK=
K-562M2Sybmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MknRTWM2OD1{OD60NVg{KM7:TR?=NIHxZ2pUSU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo BEZ235 induces regression of the tumors (69%) without statistically significant effect on body weight gain. Altogether, these preliminary in vivo efficacy results show that BEZ235 causes disease stasis when administered orally as a single agent and can enhance the efficacy of other anticancer agents when used in combination studies. [1]
Features

Protocol(Only for Reference)

Kinase Assay:

[1]

In vitro Protein Kinase, PI3K, and mTOR Assays PI3Kα, β, and δ proteins are composed of the iSH2 domain of p85 NH2-terminally fused to the full-length protein p110 protein, with the exception of α that also does not contain the last 20 amino acids. PI3Kγ is produced as full-length protein deleted for its first 144 amino acids. All constructs are fused to a COOH-terminal His tag for convenient purification and then cloned into the pBlue-Bac4.5 (for α, β, and δ isoforms) or pVL1393 (for γ isoform) plasmids. The different vectors are then cotransfected with BaculoGold WT genomic DNA using methods recommended by the vendor for production of the respective recombinant baculoviruses and proteins. BEZ235 are tested for their activity against PI3K using a Kinase-Glo assay. The kinase reaction is done in 384-well black plate. Each well is loaded with 50 μL of test items (in 90% DMSO) and 5 μL reaction buffer containing 10 μg/mL PI substrate (l-α-phosphatidylinositol; Avanti Polar Lipids; prepared in 3% octyl-glucoside) and the PI3K proteins (10, 25, 10, and 150 nM of p110α, p110β, p110δ, and p110γ, respectively) are then added to it. The reaction is started by the addition of 5 μL of 1 μM ATP prepared in the reaction buffer and is incubated for either 60 (for p110α, p110β, and p110δ) or 120 min (for p110γ). It is terminated by the addition of 10 μL Kinase-Glo buffer. The plates are then read in a Synergy 2 reader for luminescence detection.

Cell Assay:

[2]

Cell lines HCT116, DLD-1 and SW480 cells
Concentrations 0-1 μM
Incubation Time 48 hours
Method

The human CRC cell lines, HCT116 (PIK3CA mutant; kinase domain at H1047R), DLD-1 (PIK3CA mutant; helical domain at E545K), and SW480 (PIK3CA wild-type) and isogenic DLD-1 PIK3CA mutant as well as wild-type cells are maintained in DMEM with 10% FBS and 1 × Penicillin/Streptomycin. Cells are plated at different initial densities (HCT116: 3 × 103 cells/well, DLD-1: 5.5 × 103 cells/well, SW480: 4.5 × 103 cells/well, DLD-1 PIK3CA mutant: 7 × 103 cells/well, and DLD-1 PIK3CA wild-type: 9 × 103 cells/well) to account for differential growth kinetics. After 16 hours, cells are incubated with increasing concentrations of BEZ235, and the drug-containing growth medium is changed every 24 hours. Cell viability is assessed 16 hours after the initial plating and 48 hours after initiation of drug treatment using the colorimetric MTS assay CellTiter 96® AQueous One Solution Cell Proliferation Assay, as per the manufacturer's instructions. Cell viability after drug treatment is normalized to that of untreated cells also grown for 48 hours. For western blot analysis, cells are plated with zero or maximum inhibitory dose (500 nM) BEZ235 for 2, 6, 24, or 48 hours.

Animal Study:

[1]

Animal Models Female Harlan athymic nude mice
Formulation NMP/polyethylene glycol 300 (10/90, v/v)
Dosages 45 mg/kg
Administration p.o.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Maira SM, et al. Mol Cancer Ther, 2008, 7(7), 1851-1863.

[2] Roper J, et al. PLoS One, 2011, 6(9), e25132.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01856101 Terminated Carcinoma Transitional Cell Cliniques universitaires Saint-Luc- Université Catholique  ...more Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Novartis February 2013 Phase 2
NCT01717898 Terminated Castrate-resistant Prostate Cancer Patients. Charles Ryan|Novartis Pharmaceuticals|University of Calif  ...more Charles Ryan|Novartis Pharmaceuticals|University of California, San Francisco January 2013 Phase 1|Phase 2
NCT01658436 Completed Pancreatic Neuroendocrine Tumors (pNET) Novartis Pharmaceuticals|Novartis November 2012 Phase 2
NCT01628913 Terminated Pancreatic Neuroendocrine Tumors (pNET) Novartis Pharmaceuticals|Novartis October 2012 Phase 2
NCT01690871 Withdrawn Malignant PEComa (Perivascular Epithelioid Cell Tumors) Novartis Pharmaceuticals|Novartis September 2012 Phase 2

view more

Chemical Information

Download BEZ235 (NVP-BEZ235, Dactolisib) SDF
Molecular Weight (MW) 469.55
Formula

C30H23N5O

CAS No. 915019-65-7
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMF 18 mg/mL warming (38.33 mM)
DMSO 0.01 mg/mL (0.02 mM)
Water <1 mg/mL (<1 mM)
In vivo NMP+polyethylene glycol 300 (10+90, v+v) 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile

Frequently Asked Questions

  • Question 1
    With difficulties in dissolving BEZ235, How can I improve its solubility?

    Answer: For in vivo study, we suggest the vehicle solution NMP/polyethylene glycol 300 (10/90, v/v). Please dissolve BEZ235 in NMP as more as possible. You can sonicate and warm it in water bath for a while. Then dilute with PEG 300.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PI3K Products

  • GDC-0032

    GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

    Features:A beta isoform-sparing PI3K inhibitor.

  • Pilaralisib (XL147)

    Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ. Phase 1/2.

  • GNE-317

    GNE-317 is a potent, brain-penetrant PI3K inhibitor.

  • LY294002

    LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation.

  • 3-Methyladenine (3-MA)

    3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.

  • CAL-101 (Idelalisib, GS-1101)

    CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM in cell-free assays; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.

  • Wortmannin

    Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

  • BKM120 (NVP-BKM120, Buparlisib)

    BKM120 (NVP-BKM120, Buparlisib) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2.

  • Pictilisib (GDC-0941)

    Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

  • Alpelisib (BYL719)

    Alpelisib (BYL719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.

Recently Viewed Items

Tags: buy BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) supplier | purchase BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) cost | BEZ235 (NVP-BEZ235, Dactolisib) manufacturer | order BEZ235 (NVP-BEZ235, Dactolisib) | BEZ235 (NVP-BEZ235, Dactolisib) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us